Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: Correlation with the clinical parameters

被引:75
作者
Takizawa, H
Satoh, M
Okazaki, H
Matsuzaki, G
Suzuki, N
Ishii, A
Suko, M
Okudaira, H
Morita, Y
Ito, K
机构
[1] Dept. of Med. and Physical Therapy, University of Tokyo, School of Medicine, Tokyo, Hongo
[2] Dept. of Med. and Physical Therapy, University of Tokyo, School of Medicine, Bunkyo-ku, Tokyo
关键词
sarcoidosis; bronchoalveolar lavage; IL-6; IL-8; IDIOPATHIC PULMONARY FIBROSIS; NECROSIS-FACTOR-ALPHA; ALVEOLAR MACROPHAGES; LYMPHOCYTES-T; INTERLEUKIN-6; DISEASE; CELLS; SECRETION; RELEASE; BSF-2;
D O I
10.1046/j.1365-2249.1997.d01-905.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A variety of cytokines have been implicated in the pathogenesis of pulmonary sarcoidosis, but the exact roles of IL-6 and IL-8 are not pet clear. We studied these cytokine levels in BALF from patients with pulmonary sarcoidosis, idiopathic pulmonary fibrosis (IPF), systemic screlosis (SSc) with interstitial lung disease and control subjects. IL-6 and IL-8 levels were significantly elevated in sarcoidosis, IPF and SSc with interstitial lung disease compared with control subjects. Subjects with sarcoidosis had significantly increased levels of both cytokines compared with controls when the cytokine values were corrected by the total albumin content and the two cytokine levels correlated with each other (r = 0.876). BALF IL-6 levels correlated with percent lymphocytes and percent CD3(+) cells. Moreover, when sarcoidosis patients were divided into three groups, those who needed steroid therapy or had progressive disease showed increased cytokine levels in BALF over stable or improved patients. These observations suggest that locally derived IL-6 and IL-8 were increased in sarcoidosis and correlated with activity of this granulomatous lung disease.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 27 条
[21]   PRODUCTION OF B-CELL STIMULATORY FACTOR-II INTERLEUKIN-6 ACTIVITY BY HUMAN-ENDOTHELIAL CELLS [J].
NORIOKA, K ;
HARA, M ;
HARIGAI, M ;
KITANI, A ;
HIROSE, T ;
SUZUKI, K ;
KAWAKAMI, M ;
TABATA, H ;
KAWAGOE, M ;
NAKAMURA, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 153 (03) :1045-1050
[22]   BRONCHIAL EPITHELIAL-CELLS RELEASE CHEMOTACTIC ACTIVITY FOR LYMPHOCYTES [J].
ROBBINS, RA ;
SHOJI, S ;
LINDER, J ;
GOSSMAN, GL ;
ALLINGTON, LA ;
KLASSEN, LW ;
RENNARD, SI .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (02) :L109-L115
[23]   SIGNIFICANCE OF INTERLEUKIN-6 IN PATIENTS WITH SARCOIDOSIS [J].
SAHASHI, K ;
INA, Y ;
TAKADA, K ;
SATO, T ;
YAMAMOTO, M ;
MORISHITA, M .
CHEST, 1994, 106 (01) :156-160
[24]   INCREASED SECRETION OF TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-1-BETA, AND INTERLEUKIN-6 BY ALVEOLAR MACROPHAGES FROM PATIENTS WITH SARCOIDOSIS [J].
STEFFEN, M ;
PETERSEN, J ;
OLDIGS, M ;
KARMEIER, A ;
MAGNUSSEN, H ;
THIELE, HG ;
RAEDLER, A .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (04) :939-949
[25]  
*SUBC SCLEOD CRIT, 1984, ARTHRITIS RHEUM, V23, P581
[26]  
THOMAS PD, 1987, AM REV RESPIR DIS, V135, P747
[27]   INTERLEUKINS IN PULMONARY SARCOIDOSIS - DISSOCIATIVE CORRELATIONS OF LUNG INTERLEUKIN-1 AND INTERLEUKIN-2 WITH THE INTENSITY OF ALVEOLITIS [J].
YAMAGUCHI, E ;
OKAZAKI, N ;
TSUNETA, Y ;
ABE, S ;
TERAI, T ;
KAWAKAMI, Y .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (03) :645-651